Artificial intelligence in mammography screening: a narrative review of progress, pitfalls, and potential
Access to this document is restricted. Some items have been embargoed at the request of the author, but will be made publicly available after the "No Access Until" date.
During the embargo period, you may request access to the item by clicking the link to the restricted file(s) and completing the request form. If we have contact information for a Cornell author, we will contact the author and request permission to provide access. If we do not have contact information for a Cornell author, or the author denies or does not respond to our inquiry, we will not be able to provide access. For more information, review our policies for restricted content.
Artificial intelligence (AI), particularly deep learning (DL), is transforming the field of medical imaging and holds substantial promise for advancing breast cancer screening. This narrative review explores current and emerging AI applications in mammography screening, including image-based cancer detection, risk prediction, and workflow optimization, with attention to technical foundations, performance metrics, and clinical utility. Evidence indicates that AI may enhance diagnostic accuracy, enable more personalized risk assessment and screening strategies, and reduce radiologist workload, which has implications for accessibility, especially in resource-limited settings with radiologist shortages. However, real-world implementation of these tools remains challenging due to limitations in algorithm generalizability to diverse populations, calibration and reader response behavior concerns, as well as regulatory, ethical and legal obstacles. While the potential impact is considerable, broader adoption will depend on prospective validation, transparent performance reporting, and strong governance mechanisms to maintain safety, equity, and public trust.